Cancer / Immunology
Verily and OneOncology Announce Collaboration to Advance Cancer Research
Verily, an Alphabet precision health technology company, and OneOncology, the national platform for independent oncology practices, have established a stra...
August 17, 2023 | News
First Patient Dosed in Phase III Prostate Cancer Imaging Study of TLX591-CDx in China
The Phase III Illuccix China study (ClinicalTrials.gov ID: NCT05847348) is a prospective, open-label, single-arm, multicenter study in Chinese...
August 11, 2023 | News
Clarity's theranostic prostate cancer trial advances to highest dose level
Highlights Cohort 2 of the theranostic SECuRE trial investigating 64Cu/67Cu SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) ha...
August 11, 2023 | News
DualityBio, BioNTech Expand Partnership for Solid Tumor Antibody-Drug Conjugate
The agreement further builds upon the strategic collaboration the companies announced in April 2023. Under the terms of the agreements, DualityBio will re...
August 08, 2023 | News
Peter Mac launches BindiMaps to help patients and visitors with vision impairments
The newly-installed service functions like Google Maps, but has been specifically developed to work indoors with a 10 to 20 times higher accuracy than GPS ...
August 03, 2023 | News
AI Medical Service Inc. Signs Joint Research Agreement with Stanford Medicine
AI Medical Service Inc. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, has signed a joint research...
July 28, 2023 | News
GC Genome Enables Prognosis Prediction and Targeted Treatment in Breast Cancer
''We can gain vital insights into patient prognosis and make informed decisions regarding the most effective treatment strategies through ctDNA CNA...
July 27, 2023 | News
HaemaLogiX, Peter MacCallum Cancer Centre Announce Myeloma CAR-T Trial Agreement
HaemaLogiX and Peter MacCallum Cancer Centre have entered a collaboration agreement to develop and conduct the first Phase I human trial of HaemaLogiX's ...
July 26, 2023 | News
Clarity reaches 50% recruitment milestone for Phase II SABRE prostate cancer trial
SABRE (Copper-64 SAR-Bombesin in Biochemical Recurrence of prostate cancer) is a Phase II Positron Emission Tomography (PET) imaging tr...
July 25, 2023 | News
BGI Genomics Global Cervical Cancer Survey Finds Young Women Have Higher Vaccination Rates but 43.5 percent Put off by Pap Smears
To further inform action to combat cervical cancer, the fourth most common cancer among women globally, BGI Genomics released its State of Cervi...
July 24, 2023 | News
Doer Biologics Announces License Agreement with BioNTech
Under the terms of the agreement, Doer Bio will grant BioNTech a worldwide license to utilize one of Doer Bio's innovative discoveries to research, develop...
July 12, 2023 | News
NK:IO Secures £1.6M Innovate UK Grant for Pioneering Cancer Therapy
Grant award of £1.6M supports program of development work with Cell and Gene Therapy Catapult NK:IO’s platform, based on pionee...
July 11, 2023 | News
3D bioprinting technology to be used for removing cancer cells
□ A three-dimensional (3D) bioprinting technology capable of eliminating cancer cells using the function of immune cells has been developed for t...
July 11, 2023 | News
280 Bio receives IND approval from the FDA for YL-17231
80Bio, Inc. a clinical stage biotechnology company focused on the development of precision oncology medicines, today announced that the U.S. Food and Drug ...
July 10, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
